Drugs / Apo-Si-K170A-C76
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07095049 | Sep 2024 → Jul 2025 overdue | COVID-19 | Interna Therapeutics Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Apo-Si-K170A-C76 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07095049 ↗ |